scorecardresearch
Add as a preferred source on Google
Saturday, October 25, 2025
TopicBioNTech

Topic: BioNTech

Pfizer Covid vaccine safe for kids aged 5-11 yrs, shows robust antibody response, trail finds

Pfizer and BioNTech SE said phase 1/2/3 trial initially enrolled up to 4,500 kids between 6 months to 11 years in the US, Finland, Poland & Spain from over 90 clinical trial sites.

Beijing delay in approving Pfizer-BioNTech shot raises questions on China’s vaccination plans

Analysts say Beijing's concern might be that approval of the BioNTech shot could be interpreted as an acknowledgment that local shots are less effective than western ones.

8-10 week gap between Pfizer doses boosts antibodies, UK study says

The study said neutralising antibody levels were twice as high after the 10-week interval as with the three-week span.

BioNTech vaccine creates 10 times higher antibody levels compared to Sinovac: Study in Lancet

Researchers noted that antibody concentrations for BioNTech recipients rose 'substantially' after first dose, but Sinovac recipients showed 'low' level of antibodies after first shot.

Could a simple pill beat Covid-19? Pfizer is giving it a go

Where most antiviral agents target the inflammatory and immune response resulting from Covid, Pfizer’s pill directly targets the virus itself.

Pfizer vaccine shows 100% efficacy in 12-15 year olds, is safe for adolescents, US study finds

Study finds Pfizer-BioNTech vaccine has favourable safety profile in 12-15-year-olds, produces greater immune response than in young adults, is highly effective against Covid-19.

Pfizer-BioNTech Covid vaccine cleared for use on adolescents aged 12-15 in US

A group of advisers to Centers for Disease Control and Prevention will meet Wednesday to make recommendations for administering the vaccine. Kids could begin receiving them Thursday.

Discussions on with Indian govt for expedited approval of Pfizer Covid vaccine, says CEO

Pfizer is aware that access to vaccines is critical. Unfortunately, our vaccine is not registered in India although our application was submitted months ago, the CEO added.

Covid-19 pandemic: France lax in containing cases, Palestine wants vaccines from Israel

As the Covid-19 pandemic shows no signs of letting up, ThePrint highlights the most important stories on the crisis from across the globe.

Pfizer-BioNTech vaccine neutralises Brazilian Covid strain in lab experiments

While the research, performed by University of Texas Medical Branch in Galveston, needs to be validated with real-world data, it offers another reason for optimism.

On Camera

The Press is not artillery — neither for the ruling party nor the Opposition: Sachin Sen

The Press in a liberal democracy has to be a forum for the expression of different points of view. It must not suppress, taint or adulterate news, wrote Sachin Sen in 1960.

US sanctions Rosneft & Lukoil: What we know of 2 oil giants that produce half of Russia’s crude

Rosneft, the Russian state-owned oil behemoth, has large interests in India. Reliance has a contract to purchase 500,000 barrels of crude per day from the firm.

From battle of wits and daring air strikes to artillery fury, new details emerge of Operation Sindoor

Fresh details of operation conducted by IAF, Army have come out in gazette notification giving citations of those who were awarded Vir Chakra for their bravery.

Deepfake on duty: when I asked AI to read Op Sindoor citations

On 21 Oct, a buzz went up that the govt had released full list of gallantry award recipients along with Op Sindoor citations. I put an AI caddy on the job. It took me into a never-ending rabbit hole.